Patrick Van Dreden

2.3k citations

101 papers · 1.4k indexed · h-index 19

Internal Medicine top 0.5%
- Venous Thromboembolism Diagnosis and Management 40
Hematology top 1%
- Blood Coagulation and Thrombosis Mechanisms 44
- Platelet Disorders and Treatments 9
Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 11
Obstetrics and Gynecology top 5%
Cardiology and Cardiovascular Medicine top 5%
- Atrial Fibrillation Management and Outcomes 12
- Acute Myocardial Infarction Research 9
Surgery
- Heparin-Induced Thrombocytopenia and Thrombosis 10
Infectious Diseases
- COVID-19 Clinical Research Studies 10

Co-authors: Grigoris Gerotziafas Aurélie Rousseau Ismaı̈l Elalamy M Samama J. Conard M.H. Horellou Barry W. Festoff Luca Cucullo
Cited by: Internal Medicine Hematology Genetics
Journals: Blood (15 papers)Thrombosis Research (13 papers)Thrombosis and Haemostasis (10 papers)
Partner nations: France Greece United States

In The Last Decade

Patrick Van Dreden

93 papers receiving 1.4k citations

Peers

Countries citing papers authored by Patrick Van Dreden

Since Specialization

Citations

This map shows the geographic impact of Patrick Van Dreden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Van Dreden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Van Dreden more than expected).

Fields of papers citing papers by Patrick Van Dreden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Van Dreden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Van Dreden. The network helps show where Patrick Van Dreden may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Patrick Van Dreden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Patrick Van Dreden Line = papers co-authored together Patrick Van Dreden links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Immune paradoxes of vaccine-induced thrombotic thrombocytopenia (VITТ), heparin-induced thrombocytopenia (HIT) and thrombosis: from general mechanisms to the unique VITТ and HIT course Obstetrics Gynecology and Reproduction ·А. D. Makatsariya,Alyssa Braxton,Benoni Dominica Kurniawan,В. О. Бицадзе,J. Kh. Khizroeva,M. V. Tretyakova,大久保政芳,Ian Horder,S.J. Nasuto,姚晓黎,И. А. Степанов,Ichiro SAKAMOTO,Z. Maulidah,Haruo Matuda,João Batista Viana Neto,Д. В. Блинов,Patrick Van Dreden,Jean‐Christophe Gris,Ismaı̈l Elalamy,Grigoris Gerotziafas	2025	0
2	Influence of Direct Oral Anticoagulant Levels and Thrombin Generation on Postoperative Bleeding [SONAR]: A Nested Case–Control Study Thrombosis and Haemostasis ·Joseph R. Shaw,Na Li,Juandi Hadi,Patrick Van Dreden,吉原直樹,Joanne Duncan,Alex C. Spyropoulos,Sam Schulman,Cornelia Titzmann,Marc Carrier,Rin-Ichiro Taniquch	2025	1
3	The procoagulant signature of cancer cells drives fibrin network formation in tumor microenvironment and impacts its quality. Implications in cancer cell migration and the resistance to anticancer agents Thrombosis Research ·Alireza Karami,Elisabeth Mbemba,J. I. Bakker,宗明和久,Aurélie Rousseau,Eleftheria Lefkou,Michèle Sabbah,Patrick Van Dreden,Grigoris Gerotziafas	2024	7
4	Evaluation of Clinical Risk Factors and Thrombosis-Related Biomarkers in Newly Diagnosed Patients with Multiple Myeloma at Risk for Cancer-Associated Thrombosis. the Observational Roadmat-CAT-MM Study Blood ·Patrick Van Dreden,Kentaro Watanabe,Eleftheria Lefkou,Despina Fotiou,Efstathios Kastritis,Evangelos Terpos,Aurélie Rousseau,Michèle Sabbah,Juandi Hadi,Ismaı̈l Elalamy,Elisabeth Mbemba,Meletios Α. Dimopoulos,Grigoris Gerotziafas	2023	1
5	Effect of PCC on Thrombin Generation among Patients on Factor Xa Inhibitors with Major Bleeding or Needing Urgent Surgery (GAUGE): Design and Rationale SHILAP Revista de lepidopterología ·Joseph R. Shaw,Jane N O T S O N,Sagi Chen,Deborah Siegal,Lana A. Castellucci,Patrick Van Dreden,Dar Dowlatshahi,Hye-Young Cho,Tim Ramsay,Marc Carrier	2023	3
6	Endothelial dysfunction and hypercoagulability in severe sickle-cell acute chest syndrome ERJ Open Research ·Étienne-Marie Jutant,Guillaume Voiriot,Vincent Labbé,Laurent Savale,M Zu,Patrick Van Dreden,Grigoris Gerotziafas,Muriel Fartoukh	2021	3
7	Overview of risk assessment models for venous thromboembolism in ambulatory patients with cancer Thrombosis Research ·Grigoris Gerotziafas,Isabelle Mahé,Eleftheria Lefkou,Nur Hikmah Umar,修盛富永,Alì Taher,Darko Antić,Ismaı̈l Elalamy,Kostas Syrigos,Patrick Van Dreden	2020	16
8	Comparison of antithrombin‐dependent and direct inhibitors of factor Xa or thrombin on the kinetics and qualitative characteristics of blood clots Research and Practice in Thrombosis and Haemostasis ·Minshu Chen,Kentaro Watanabe,Annette K. Larsen,Patrick Van Dreden,Desislava Zhelyazkova,Dennis V. Cokkinos,Ismaı̈l Elalamy,Grigoris Gerotziafas	2018	14
9	Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: results of the prospective ROADMAP-MM-CAT study Blood Cancer Journal ·Despina Fotiou,Theodoros Ν. Sergentanis,Kentaro Watanabe,Kimon Stamatelopoulos,Maria Gavriatopoulou,Efstathios Kastritis,Θεοδώρα Ψαλτοπούλου,Minshu Chen,Patrick Van Dreden,P. Karami,Annette K. Larsen,Evangelos Terpos,Ismaı̈l Elalamy,Meletios Α. Dimopoulos,Grigoris Gerotziafas	2018	25
10	OC-03 - Modelisation of the procoagulant properties of cancer cells and their capacity to alter the antithrombotic efficiency of LMWHs and specific inhibitors of factor Xa Thrombosis Research ·Grigoris Gerotziafas,Aurélie Rousseau,Patrick Van Dreden,Elisabeth Mbemba,Li Xu,牛宪纲,A. Larsen,Ismaı̈l Elalamy	2016	1
11	Decreased levels of procoagulant phospholipids in bleeding patients treated by vitamin K antagonists Thrombosis Research ·Emmanuel Mathieu,Patrick Van Dreden,Sergio Iván Hernández Rangel,Juandi Hadi,Jean‐François Dreyfus,Dominique François,Marc Vasse	2015	1
12	Effect of Low Molecular Weight Heparins and Fondaparinux Upon Thrombin Generation Triggered by Human Pancreatic Cancer Cells BXPC3 Current Vascular Pharmacology ·Grigoris Gerotziafas,Cheng-Yu Tsai,Elisabeth Mbemba,R. N. Kalantarov,Bryam Mateo López-Farfán,牛宪纲,Patrick Van Dreden,L.P. Stems,E. Koutaissoff,Jean‐François Bernaudin,Jawed Fareed,Mohamed Hatmi,Ismaı̈l Elalamy	2014	11
13	The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles Thrombosis and Haemostasis ·Grigoris Gerotziafas,Patrick Van Dreden,S B Rosser,Cheng-Yu Tsai,牛宪纲,François Lionnet,慧芳何,Olivier Blanc‐Brude,Barry Woodhams,Micheline Maïer-Redelsperger,Robert Girot,Mohamed Hatmi,Ismaı̈l Elalamy	2012	56
14	Decreased procoagulant phospholipids in patients treated by vitamin K antagonists Thrombosis Research ·Aurélie Rousseau,Barry Woodhams,SebastianKalamajski,Patrick Van Dreden,Hatice Uslu,M. Bawudong,Bernard Lenormand,Marc Vasse	2012	2
15	Decreased activity of soluble thrombomodulin and plasma procoagulant phospholipids in childhood bone marrow transplantation with severe complications Thrombosis Research ·Pascale Schneider,Patrick Van Dreden,Aurélie Rousseau,Aude Marie‐Cardine,Estelle Houivet,Jean‐Pierre Vannier,Marc Vasse	2011	4
16	Comparative evaluation of Tissue factor and Thrombomodulin activity changes during normal and idiopathic early and late foetal loss: The cause of hypercoagulability? Thrombosis Research ·Patrick Van Dreden,Barry Woodhams,Aurélie Rousseau,Marie Favier,Rémi Favier	2011	12
17	Comparison of the effect of fondaparinux and enoxaparin on thrombin generation during in-vitro clotting of whole blood and platelet-rich plasma Blood Coagulation & Fibrinolysis ·Grigoris Gerotziafas,François Depasse,Tahar Chakroun,Patrick Van Dreden,M Samama,Ismaı̈l Elalamy	2004	34
18	Assessment of activated protein C resistance using a new and rapid venom-based test Blood Coagulation & Fibrinolysis ·Emmanuel Oger,Christophe Leroyer,B. Mercier,Patrick Van Dreden,Luc Bressollette,Luc de Saint Martin,Emmanuelle Le Moigne,Hideki Terakawa,Amy N. Allan,Jean Amiral,S Yokoyama,JF Abgrall,Dominique Mottier	1998	9
19	Protein composition of follicular fluid and oocyte cleavage occurrence in in vitro fertilization (IVF) Journal of Assisted Reproduction and Genetics ·Jacques Gonzalès,Chengzong Zeng,Patrick Van Dreden,Peter Richard,Gilles Lefèbvre,Chauncey Crandall	1992	17
20	Déficit en protéine C et risque thromboembolique La Presse Médicale ·M.H. Horellou,J Conard,Patrick Van Dreden,Howard C. Cross	1986	1

About Patrick Van Dreden

Patrick Van Dreden is a scholar working on Internal Medicine, Hematology and Genetics, having authored 101 papers that have together received 1.4k indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (44 papers), Venous Thromboembolism Diagnosis and Management (40 papers), Atrial Fibrillation Management and Outcomes (12 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers), Heparin-Induced Thrombocytopenia and Thrombosis (10 papers), COVID-19 Clinical Research Studies (10 papers), Acute Myocardial Infarction Research (9 papers) and Platelet Disorders and Treatments (9 papers). The work is most often cited by research in Internal Medicine (543 citations), Hematology (696 citations) and Genetics (164 citations). Patrick Van Dreden has collaborated with scholars based in France, Greece and United States. Frequent co-authors include Grigoris Gerotziafas, Aurélie Rousseau, Ismaı̈l Elalamy, M Samama, J. Conard, M.H. Horellou, Barry W. Festoff, Luca Cucullo, Thomas Lecompte and Ravi K. Sajja. Their work appears in journals such as Blood, Thrombosis Research, Thrombosis and Haemostasis, Blood Coagulation & Fibrinolysis and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact